Skip to main content
Account

Peer review reports

From: A retrospective study on the efficacy and safety of Endostar with chemotherapy in EGFR-TKI-resistant NSCLC

Original Submission
17 Dec 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
17 Aug 2023 Reviewed Reviewer Report
23 Aug 2023 Reviewed Reviewer Report
25 Sep 2023 Author responded Author comments - nan zhang
Resubmission - Version 3
25 Sep 2023 Submitted Manuscript version 3
26 Sep 2023 Author responded Author comments - nan zhang
Resubmission - Version 4
26 Sep 2023 Submitted Manuscript version 4
27 Sep 2023 Reviewed Reviewer Report
11 Oct 2023 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
11 Oct 2023 Editorially accepted
11 Nov 2023 Article published 10.1186/s12890-023-02705-z

Learn about peer review

Back to article page

Navigation